Tao Lv

573 total citations
11 papers, 453 citations indexed

About

Tao Lv is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tao Lv has authored 11 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tao Lv's work include Cancer-related molecular mechanisms research (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (2 papers). Tao Lv is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (2 papers). Tao Lv collaborates with scholars based in China and Sweden. Tao Lv's co-authors include Zeyuan Zhong, Zhi Qian, Shuo Ni, Baoqing Yu, Yanbin Kuang, Yuan Yin, Yu Zhu, Huimin An, Jianping Zhang and Le Xu and has published in prestigious journals such as PLoS ONE, Free Radical Biology and Medicine and Redox Biology.

In The Last Decade

Tao Lv

11 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tao Lv China 9 272 182 144 63 44 11 453
Denise R. Minton United States 7 291 1.1× 164 0.9× 97 0.7× 40 0.6× 56 1.3× 7 465
Parker L. Sulkowski United States 9 487 1.8× 211 1.2× 89 0.6× 122 1.9× 19 0.4× 10 681
Di Yang China 9 333 1.2× 121 0.7× 94 0.7× 72 1.1× 47 1.1× 21 435
Aihua Sui China 14 310 1.1× 171 0.9× 41 0.3× 87 1.4× 23 0.5× 38 491
Changliang Peng China 14 297 1.1× 123 0.7× 93 0.6× 103 1.6× 15 0.3× 27 482
He Tian China 13 194 0.7× 94 0.5× 68 0.5× 55 0.9× 19 0.4× 35 363
Yangjia Zhuo China 16 436 1.6× 282 1.5× 185 1.3× 92 1.5× 8 0.2× 44 674

Countries citing papers authored by Tao Lv

Since Specialization
Citations

This map shows the geographic impact of Tao Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Lv more than expected).

Fields of papers citing papers by Tao Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Lv. The network helps show where Tao Lv may publish in the future.

Co-authorship network of co-authors of Tao Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Lv. A scholar is included among the top collaborators of Tao Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Lv. Tao Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zhong, Zeyuan, Chong‐Jing Zhang, Shuo Ni, et al.. (2023). NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors. Redox Biology. 63. 102711–102711. 60 indexed citations
2.
Lv, Tao, et al.. (2022). Injectable, Anti-Cancer Drug-Eluted Chitosan Microspheres against Osteosarcoma. Journal of Functional Biomaterials. 13(3). 91–91. 8 indexed citations
3.
Lv, Tao, et al.. (2022). Oxyresveratrol Reduces the Migration of Human Osteosarcoma Cell U2OS via Attenuating STAT3 Activation. Natural Product Communications. 17(6). 2 indexed citations
4.
Lv, Tao, et al.. (2021). uPAR: An Essential Factor for Tumor Development. Journal of Cancer. 12(23). 7026–7040. 29 indexed citations
5.
Ni, Shuo, Yuan Yin, Zhi Qian, et al.. (2021). Hypoxia inhibits RANKL-induced ferritinophagy and protects osteoclasts from ferroptosis. Free Radical Biology and Medicine. 169. 271–282. 139 indexed citations
6.
7.
Lv, Tao, et al.. (2020). Oxyresveratrol induces apoptosis and inhibits cell viability via inhibition of the STAT3 signaling pathway in Saos‑2 cells. Molecular Medicine Reports. 22(6). 5191–5198. 10 indexed citations
8.
Lv, Tao, et al.. (2018). LncRNA UCA1 sponges miR-204-5p to promote migration, invasion and epithelial-mesenchymal transition of glioma cells via upregulation of ZEB1. Pathology - Research and Practice. 214(9). 1474–1481. 44 indexed citations
9.
Lv, Tao, Yanfeng Liu, Jianping Zhang, et al.. (2014). Impact of an Altered PROX1 Expression on Clinicopathology, Prognosis and Progression in Renal Cell Carcinoma. PLoS ONE. 9(5). e95996–e95996. 11 indexed citations
10.
Zhu, Yu, Le Xu, Jianping Zhang, et al.. (2013). Sunitinib induces cellular senescence via p53/Dec1 activation in renal cell carcinoma cells. Cancer Science. 104(8). 1052–1061. 63 indexed citations
11.
Zhu, Yu, Le Xu, Jianping Zhang, et al.. (2013). Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3β/Snail signaling in renal cell carcinoma. Cancer Science. 104(6). 663–671. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denise R. Minton Breakdown of academic impact, for papers by Parker L. Sulkowski Breakdown of academic impact, for papers by Di Yang Breakdown of academic impact, for papers by Aihua Sui Breakdown of academic impact, for papers by Changliang Peng Breakdown of academic impact, for papers by He Tian Breakdown of academic impact, for papers by Yangjia Zhuo
Rankless by CCL
2026